Directed Surface Reconstruction of Fe Modified Co2VO4 Spinel Oxides for Water Oxidation Catalysts Experiencing Self-Terminating Surface Deterioration.

Affordable highly efficient catalysts for electrochemical oxygen evolution reaction (OER) play pivotal roles in green hydrogen production via water electrolysis. Regarding the non-noble metal-based electrocatalysts, considerable efforts are made to decipher the cation leaching and surface reconstruction; yet, little attention is focused on correlating them with catalytical activity and stability. Herein, in situ reconstruction of Fe-modified Co2VO4 precursor catalyst to form a highly active (Fe,V)-doped CoOOH phase for OER is reported, during which partial leaching of V accelerates the surface reconstruction and the V reserved in the reconstructed CoOOH layer in the form of alkali-resistant V2O3 serves for dynamic charge compensation and prevention of excessive loss of lattice oxygen and Co dissolution. Fe substitution facilitates Co pre-oxidation and endows the catalysts with structural flexibility by elevating O 2p band level; hence, encouraging participation of lattice oxygen in OER. The optimized Co2Fe0.25V0.75O4 electrode can afford current densities of 10 and 500 mA cm-2 at low overpotentials of 205 and 320 mV, respectively, with satisfactory stability over 600 h. By coupling with Pt/C cathode, the assembled alkaline electrolyzer can deliver 500 mA cm-2 at a low cell voltage of 1.798 V, better than that of commercial RuO2 (+) || Pt/C (-).

In situ reconstruction of self-supported NiFeP electrodes for overall water splitting at large current density.

In this study, self-supported NiFeP was fabricated on Ni mesh (NiFeP/NM) via a two-step monopulse electrodeposition and phosphorization strategy. The NiFeP/NM exhibited excellent activity through electrochemical surface reconstruction to generate true active sites, requiring low overpotentials of 349 mV and 310 mV to reach a current density of 500 mA cm-2 for the HER and OER, respectively, and exhibiting satisfactory stability in 6 M NaOH.

Synthesis and Herbicidal Activity of Triketone-Quinoline Hybrids as Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors.

4-Hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27, HPPD) is one of the most important targets for herbicide discovery. In the search for new HPPD inhibitors with novel scaffolds, triketone-quinoline hybrids were designed and subsequently optimized on the basis of the structure-activity relationship (SAR) studies. Most of the synthesized compounds displayed potent inhibition of Arabidopsis thaliana HPPD (AtHPPD), and some of them exhibited broad-spectrum and promising herbicidal activity at the rate of 150 g ai/ha by postemergence application. Most promisingly, compound III-l, 3-hydroxy-2-(2-methoxy-7-(methylthio)quinoline-3-carbonyl)cyclohex-2-enone (Ki = 0.009 µM, AtHPPD), had broader spectrum of weed control than mesotrione. Furthermore, compound III-l was much safer to maize at the rate of 150 g ai/ha than mesotrione, demonstrating its great potential as herbicide for weed control in maize fields. Therefore, triketone-quinoline hybrids may serve as new lead structures for novel herbicide discovery.

Design, synthesis and herbicidal activity of novel quinazoline-2,4-diones as 4-hydroxyphenylpyruvate dioxygenase inhibitors.

BACKGROUND: 4-Hydroxyphenylpyruvate dioxygenase (HPPD) (EC 1.13.11.27) has been identified as one of the most promising target sites for herbicide discovery. To discover novel HPPD inhibitors with high herbicidal activity and improved crop selectivity, a series of novel triketone-containing quinazoline-2,4-dione derivatives possessing a variety of substituents at the N-1 position of the quinazoline-2,4-dione ring were designed and synthesised. RESULTS: The results of in vitro tests and greenhouse experiments indicated that some analogues showed good HPPD inhibitory activity, with promising broad-spectrum herbicidal activity at a rate of 150 g AI ha(-1) . Most surprisingly, compound 11 h, 1-ethyl-6-(2-hydroxy-6-oxocyclohex-1-enecarbonyl)-3-(o-tolyl)quinazoline-2,4(1H,3H)-dione, showed the highest HPPD inhibition activity, with a Ki value of 0.005 µM, about 2 times more potent than mesotrione (Ki = 0.013 µM). Further greenhouse experiments indicated that compounds 11d and 11 h displayed strong and broad-spectrum post-emergent herbicidal activity even at a dosage as low as 37.5 g AI ha(-1) , which was superior to mesotrione. More importantly, compounds 11d and 11 h were safe for maize at a rate of 150 g AI ha(-1) , and compound 11d was safe for wheat as well. CONCLUSION: The present work indicated that the triketone-containing quinazoline-2,4-dione motif could be a potential lead structure for further development of novel herbicides.

Synthesis and herbicidal evaluation of triketone-containing quinazoline-2,4-diones.

Exploring novel 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27, HPPD) inhibitors is one of the most promising research directions in herbicide discovery. To discover new triketone herbicides with broad-spectrum weed control as well as excellent crop selectivity, a series of (total 52) novel triketone-containing quinazoline-2,4-dione derivatives were synthesized and further bioevaluated. The greenhouse testing indicated that many of the newly synthesized compounds showed better or excellent herbicidal activity against broadleaf and monocotyledonous weeds at the dosages of 37.5-150 g of active ingredient (ai)/ha. The structure and activity relationship in this study indicated that the triketone-containing quinazoline-2,4-dione motif has possessed great impact on herbicide activity and may be used for further optimization. Among the new compounds, III-b and VI-a-VI-d displayed a broader spectrum of weed control than mesotrione. In addition, the compound III-b also demonstrated comparatively superior crop selectivity to mesotrione, thus possessing great potential for weed control in the field.

Pyrazolone-quinazolone hybrids: a novel class of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.

4-Hydroxyphenylpyruvate dioxygenase (HPPD), converting 4-hydroxyphenylpyruvate acid to homogentisate, is an important target for treating type I tyrosinemia and alkaptonuria due to its significant role in tyrosine catabolism. However, only one commercial drug, NTBC, also known as nitisinone, has been available for clinical use so far. Herein, we have elucidated the structure-based design of a series of pyrazolone-quinazolone hybrids that are novel potent human HPPD inhibitors through the successful integration of various techniques including computational simulations, organic synthesis, and biochemical characterization. Most of the new compounds displayed potent inhibitory activity against the recombinant human HPPD in nanomolar range. Compounds 3h and 3u were identified as the most potent candidates with Ki values of around 10 nM against human HPPD, about three-fold more potent than NTBC. Molecular modeling indicated that the interaction between the pyrazolone ring and ferrous ion, and the hydrophobic interaction of quinazolone with its surrounding residues, such as Phe347 and Phe364, contributed greatly to the high potency of these inhibitors. Therefore, compounds 3h and 3u could be potentially useful for the treatment of type I tyrosinemia and other diseases with defects in tyrosine degradation.

Understanding resistance mechanism of protoporphyrinogen oxidase-inhibiting herbicides: insights from computational mutation scanning and site-directed mutagenesis.

The potential of protoporphyrinogen oxidase (PPO) to develop resistance against five PPO-inhibiting herbicides has been studied using computational mutation scanning (CMS) protocol, leading to valuable insights into the resistance mechanisms and structure-resistance relationship of the PPO inhibitors. The calculated shifts in the binding free energies caused by the mutations correlated very well with those derived from the corresponding experimental data obtained from site-directed mutagenesis of PPO, leading to valuable insights into the resistance mechanisms of PPO inhibitors. The calculated entropy change was related to the conformational flexibility of the inhibitor, which demonstrated that inhibitors with appropriate conformational flexibility may inhibit both the wild type and mutants simultaneously. The reasonable correlation between the computational and experimental data further validate that CMS protocol is valuable for predicting resistance associated with amino acid mutations on target proteins.